We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRT
10751
PUT
DELISTED
Assertio
ASRT
-222
Closed -$9K
ATR icon
10752
PUT
AptarGroup
ATR
$8.77B
-1,900
Closed -$215K
ATRC icon
10753
PUT
AtriCure
ATRC
$2.01B
-6,700
Closed -$267K
AVA icon
10754
Avista
AVA
$3.27B
-33,535
Closed -$1.23M
AVA icon
10755
PUT
Avista
AVA
$3.27B
-10,700
Closed -$365K
AVNS
10756
DELISTED
Avanos Medical
AVNS
-53,030
Closed -$2.21M
AVNS
10757
PUT
DELISTED
Avanos Medical
AVNS
-13,700
Closed -$455K
AVTX icon
10758
Avalo Therapeutics
AVTX
$962M
-5
Closed -$32K
AVUV icon
10759
Avantis US Small Cap Value ETF
AVUV
$30.7B
-14,599
Closed -$625K
AZZ icon
10760
PUT
AZZ Inc
AZZ
$4.37B
-10,200
Closed -$348K
BBDC icon
10761
CALL
Barings BDC
BBDC
$871M
-13,000
Closed -$104K
BBIO icon
10762
PUT
BridgeBio Pharma
BBIO
$15.6B
-7,200
Closed -$270K
BBRE icon
10763
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.29B
-10,123
Closed -$728K
BBUS icon
10764
JPMorgan BetaBuilders US Equity ETF
BBUS
$8.92B
-41,741
Closed -$2.55M
BBW icon
10765
Build-A-Bear
BBW
$436M
-14,746
Closed -$37K
BCX icon
10766
BlackRock Resources & Commodities Strategy Trust
BCX
$916M
-13,443
Closed -$80K
BDEC icon
10767
Innovator US Equity Buffer ETF December
BDEC
$218M
-36,144
Closed -$1.01M
BDC icon
10768
CALL
Belden
BDC
$4.9B
-14,700
Closed -$457K
BDJ icon
10769
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
-22,925
Closed -$168K
BEDU
10770
DELISTED
Bright Scholar Education Holdings
BEDU
-2,614
Closed -$67K
BETZ icon
10771
Roundhill Sports Betting & iGaming ETF
BETZ
$48.4M
-159,010
Closed -$3.63M
BF.B icon
10772
PUT
Brown-Forman Class B
BF.B
$13.4B
-3,200
Closed -$241K
BIO icon
10773
Bio-Rad Laboratories Class A
BIO
$8.76B
-4,748
Closed -$2.45M
BIP icon
10774
Brookfield Infrastructure Partners
BIP
$19.2B
-42,191
Closed -$1.37M
BIS icon
10775
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.32M
-4,104
Closed -$254K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.